Three things to know:
1. The compound annual growth rate for the orthopedic regenerative surgical product market is forecast to rise 3.9 percent between 2022 and 2030, according to an April 21 news release.
2. Key market growth drivers include the rising aging population, research and development in regenerative medicine and growing need for orthopedic care.
3. Market players named in the report include Zimmer Biomet, Stryker, Smith+Nephew and Allosource.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
